Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Eye (Lond) ; 23(11): 2099-104, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19098700

RESUMO

PURPOSE: Dendritic cells (DCs) express the high-affinity receptor for IgE (Fc(epsilon)RI) on their surface, which may enhance their ability to capture and internalize antigens for presentation to T-lymphocytes. The aim of this study was to determine if expression of Fc(epsilon)RI(+) DCs is increased in the conjunctivae of vernal keratoconjunctivitis (VKC) patients compared with those of normal controls. METHODS: Conjunctival biopsies were obtained from non-atopic and VKC patients. Double immunohistochemical staining was carried out using antibodies against Fc(epsilon)RI and the CD1a antigen, a DC marker. The double-positive cells were counted in five representative fields of view for each conjunctival sample. RESULTS: Fc(epsilon)RI(+) CD1a(+) cells were present in significantly higher numbers in VKC conjunctivae compared with normal controls (mean cell count of 21.3 in VKC vs5.0 in controls, P<0.005). In normal patients the Fc(epsilon)RI-expressing DCs tended to be confined to the epithelial layer or the superficial substantia propria, but in the VKC samples these Fc(epsilon)RI(+) cells were mainly concentrated in the deeper substantia propria. CONCLUSIONS: Fc(epsilon)RI(+) DC numbers are elevated in the conjunctivae of VKC patients, a finding consistent with the results of other studies focusing on atopic conditions. Elevated expression of Fc(epsilon)RI on DCs would facilitate antigen presentation and enhance T-cell priming, thereby contributing to ocular symptoms.


Assuntos
Conjuntivite Alérgica/metabolismo , Células Dendríticas/metabolismo , Receptores de IgE/metabolismo , Túnica Conjuntiva/metabolismo , Células Dendríticas/citologia , Humanos , Imuno-Histoquímica , Fenótipo
2.
Cephalalgia ; 27(3): 275-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17381560

RESUMO

The features and management of two adult patients with ophthalmoplegic migraine and longlasting sixth nerve palsies are described. Both had had previous shorter episodes of diplopia following migraine-like headaches. One recovered following an injection of botulinum toxin to the medial rectus of her affected eye 11 months after the onset of diplopia. The other patient had previously had surgery for a consecutive divergent squint and required further squint surgery to realign his eyes 1 year after the onset of his sixth nerve palsy. Both botulinum toxin and squint surgery may be useful in the management of longstanding sixth nerve palsy in patients with ophthalmoplegic migraine. The aetiology of ophthalmoplegic migraine is discussed.


Assuntos
Doenças do Nervo Abducente/etiologia , Doenças do Nervo Abducente/terapia , Oftalmopatias/terapia , Transtornos de Enxaqueca/etiologia , Transtornos de Enxaqueca/prevenção & controle , Oftalmoplegia/complicações , Oftalmoplegia/terapia , Adulto , Feminino , Humanos , Masculino , Resultado do Tratamento
5.
Expert Opin Pharmacother ; 2(11): 1849-57, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11825321

RESUMO

Fungal eye infections are rare. Trauma associated with contamination by vegetative material, contact lens wear and long term corticosteroid use are common risk factors. The aims of treatment are to preserve visual function, which depends on the rapid diagnosis and efficient administration of appropriate antifungal therapy. This necessitates a clinical suspicion of fungal aetiology and the taking of appropriate smears and cultures as early as possible to identify the fungal organism. Currently there are three main classes of drugs available for use in fungal eye infections: polyenes, azoles as derivatives of imidazoles, and 5-fluorocytosine. Of the polyenes, amphotericin B, natamycin and nystatin are of clinical ophthalmic use. Based on better pharmacokinetic profiles and spectra of antifungal activity, the triazoles are the agents of choice. Successful treatment of fungal keratitis depends on early initiation of specific therapy consisting of topically-applied antifungal agents since topical administration is most likely to provide the best opportunity for achieving therapeutic corneal levels. Hence, the molecular weight of the various antifungal agents is of importance since it influences their ability to penetrate the corneal epithelium. Systemic administration may be necessary for resistant fungal ulcers. For fungal endophthalmitis, to preserve visual function and eliminate the fungal pathogen, topical, systemic and possibly intraocular antifungal therapy is used, although some do not recommend use of systemic agents for exogenous endophthalmitis.


Assuntos
Antifúngicos/uso terapêutico , Infecções Oculares Fúngicas/tratamento farmacológico , Anti-Inflamatórios/uso terapêutico , Antifúngicos/economia , Infecções Oculares Fúngicas/economia , Infecções Oculares Fúngicas/microbiologia , Infecções Oculares Fúngicas/patologia , Humanos , Esteroides
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA